Since more than a quarter of MB patients show activation of the SHH signaling pathway shown by GLI2/1 immunopositivity,11,39 activated forms of GLI2 preserve pathway activity and support survival of the tumor cells, indicating GLI2 activity as a key driver for MB.40 This evidence concerns the gene SHH and neoplasm.